On May 7, we invite those affected by #LungCancer to join us for an informative program, conversation, and a complimentary dinner at Sweet Grass Grill in Tarrytown, NY. Meet Drs. Brendon Stiles, Balazs Halmos, Isabel Preeshagul, and nurse Peggy Collins. RSVP for #TogetherNY: LCRF.org/TogetherNY

LCRF's 2026 Gala, Sept. 23, will spotlight women facing #LungCancer with courage & resolve, women we have lost to the disease, and physicians and scientists whose leadership is reshaping outcomes for women everywhere. Our honorees are Rose Ann Weinstein and Narjust Florez, MD, FASCO. LCRF.org/gsw26

A bright future for ALK+ #LungCancer research is in the cards! Aidan is selling collectible sports trading cards as a fundraiser for a LCRF ALK+ research grant in honor of his mom, Jen. His shop be found at ebay.us/m/aINw8p. More info at LCRF.org/ALK.

Don't forget to wish your favorite doctor a #HappyDoctorsDay! We are grateful for all the docs that help us every step of our journey.

The FDA recently approved a medical device using AI-based technology for the combined detection and diagnosis of #LungCancer. LCRF's Chief Scientific Officer, Dr. Toni Wozniak, takes a look at what this development could mean for patients worldwide. LCRF.org/sms3326

Anyone with lungs can get #LungCancer, including young adults with no risk factors. Join us live Wed, April 15 at 4pm as we partner with @younglungcancer.bsky.social to talk challenges faced by younger patients and their families. All ages welcome! LCRF.org/together

Kudos to these outstanding runners who proudly represented Team LCRF in the United Airlines NYC Half! They achieved an incredible feat by completing 13.1 miles and raising vital funds for lung cancer research. Thank you for your support!

On April 14, we're bringing those in the Chicago area affected by #LungCancer together for an informative program with Dr. Christine Bestiva, Dr. Frank Weinberg, and Jill Feldman; conversation; and a complimentary dinner. RSVP to Together Chicago at Evanston Corner Bistro. LCRF.org/TogetherChicago

If you have lungs, you can get #LungCancer – even with no risk factors, and even if you're young. In our next livestream on April 15, 4-5pm ET, Drs. Eric Singhi and Isabel Preeshagul will talk about young adults getting – and living with – a diagnosis. lcrf.org/together @lungoncdoc.bsky.social

It’s what sets us apart: LCRF puts patients, caregivers, & loved ones at the center of research funding. Research advocates review proposals alongside medical experts to ensure the studies we fund reflect real needs. Let’s fund research that truly matters to those with #LungCancer. LCRF.org/ddsp26

If you have lungs, you can get #LungCancer – even if you have no risk factors, and even if you're young. In our next livestream on April 15 at 4pm ET, Drs. Eric Singhi and Isabel Preeshagul will talk about young adults getting – and living with – a lung cancer diagnosis. LCRF.org/together

The latest installment of Dr. Dhru Deb's Connecting the Dots series highlights the ALK #LungCancer breakthrough and the research that made It possible. Dr. Deb is Senior Director, Research and Administration for LCRF. www.lungcancerresearchfoundation.org/connecting-t...

Together with ALK+ patients, survivors, loved ones, industry partners, and medical leaders, we're fueling bold, life-saving research to change the future of ALK+ #LungCancer. Want to be involved? 🫱 Donate 💬 Provide insight 📨 Subscribe to updates on this research Learn more at LCRF.org/ALK.

At LCRF, people impacted by #LungCancer are at the center of everything we do. Our research advocates – patients, caregivers, and loved ones – help decide which studies get funded, so research reflects real needs and real lives. Fund research guided by those it matters to most. LCRF.org/ddsp26

Join us for the 8th Annual Purple and White Fight Night in NYC! Hosted by Ashley Katzen and Danyelle Shapiro, the event was inspired by their parents and a shared belief that awareness is hope and hope never quits. Proceeds benefit LCRF and the Hirshberg Foundation. Get your tickets at LCRF.org/PWFN

Today! Join LCRF and Medlive for our free online program: Navigating ES-SCLC Clinical Trials This session is for those living with ES-SCLC & caregivers who want to understand clinical trials, safety, and treatment options. 🕐 Today, 1 PM ET 👉 Join us live! lcrf.org/7o21l

Have you or a loved one been diagnosed with extensive-stage small-cell #LungCancer? Clinical trials may be a treatment option, but they can feel confusing. That’s why LCRF and Medlive are offering a free online session to provide answers & support. 🗓️ Live Mar 9 at 1 PM ET ✅ Join us! lcrf.org/7o21l

You are not alone in navigating lung cancer care. Join LCRF and Medlive for a free educational program for people living with ES-SCLC and their caregivers. This is a chance to learn at your own pace and feel more confident about your options. 📅 March 9 at 1 PM ET ➡️ Register now! lcrf.org/7o21l

Together with ALK+ patients, survivors, loved ones, industry partners, and medical leaders, we're fueling bold, life-saving research to change the future of ALK+ #LungCancer. Want to be involved? 🫱 Donate 💬 Provide insight 📨 Subscribe to updates on this research Learn more at LCRF.org/ALK.

📅 Save the Date! LCRF and Medlive are hosting a free online program to help people better understand clinical trials for extensive-stage small-cell lung cancer (ES-SCLC). Get supportive, patient-friendly information from experts and advocates. lcrf.org/7o21l @medliveofficial.bsky.social

In his latest Connecting the Dots article, Dhru Deb, PhD, highlights milestones and investigators who have driven the progress transforming EGFR+ #LungCancer from a mystery to something many patients now live with for years. LCRF.org/ctd22726

Small Cell #LungCancer news: A new collaboration between LCRF and AstraZeneca will fund two grants for #SCLC research. Find out more about this exciting initiative. LCRF.org/sc224

#TTLC26 - group selfie following the inspiring session on "Women in Thoracic Oncology" - LCRF Sr. Director of Research Programs, Dhru Deb; Dr. Maiyan Chau, Global Medical Affairs at AstraZeneca; Dr. Loretta Erhunmwunsee, VP Chief Health Access & Community Enrichment Officer, City of Hope +LCRF SAB

LCRF's science team hard at work at #TTLC26!

Our first Together Separately livestream of 2026 will recap IASLC's Targeted Therapies of #LungCancer meeting, which takes place this week. Sign up now and join us on Wednesday, March 11 at 4pm ET to hear updates from Dr. Joshua Reuss and our moderator, Dr. Isabel Preeshagul. LCRF.org/together

Today is #InternationalDayofWomenandGirlsinScience - and at LCRF, we are proud to support the many women who lead our research and education programs, move lung cancer research forward in the lab and in practice, and chart the course for innovation in science for the betterment of others.

In our winter science update, Aubrey Rhodes, Dr. Toni Wozniak, and Dr. Dhru Deb talk about this year’s research grant program, including research on environmental factors and #LungCancer, and how previous research is connected to treatments now benefiting patients: LCRF.org/scienceteamupdate

Today is #WorldCancerDay - and a day to celebrate a small, but hard-won victory. Yesterday, the House passed the funding measure to end the ongoing partial government shutdown, which includes funding for the Defense Appropriations Act, which provides $20 million for the Lung Cancer Research Program.

Future You will thank you for this one. Creating or updating your will is one of the most meaningful ways to plan for tomorrow. It’s quick, free, and gives you peace of mind for your future – and the future of research that improves outcomes for patients with #LungCancer. LCRF.org/qt6ay

Today is the last day of Radon Awareness Month, but it is never too late to learn more about one of the leading causes of #lungcancer. Visit LCRF.org/radon today.

#ICYMI - The FDA approved amivantamab to be given subcutaneously (under the skin) for patients whose conditions already were approved for intravenous (IV) use of this bispecific antibody. LCRF's Chief Scientific Officer, Dr. Antoinette Wozniak, explains what this means. #LungCancer LCRF.org/9906f

#ICYMI - The winter LCRF e-news is out! Read about the impact your support has on research and the future of #LungCancer. LCRF.org/enews

2025 was a tremendous year for #LungCancer research. LCRF's Chief Scientific Officer, Antoinette Wozniak, MD, outlines the developments and what they mean going forward. #ScienceMadeSimple LCRF.org/hizrw

Future You will thank you for this one. Creating or updating your will is one of the most meaningful ways to plan for tomorrow. It’s quick, free, and gives you peace of mind for your future and the future of research, to improve outcomes for patients with #LungCancer: LCRF.org/qt6ay

Radon is the 2nd leading cause of #LungCancer. The highest levels of radon are found below ground – basements, crawlspaces, foundations, and construction joints. Some states have higher levels than others. Check your state’s radon levels here: buff.ly/k3OZfbn

Take action now! Ask your representative to co-sponsor the Benay Taub Lung Cancer Research Act, a bipartisan bill that would: 🫁 Improve access to lung cancer screenings 🫁 Recommend best practices for early detection 🫁 Increase federal funding for research lungcan.org/bt

January is Radon Action & Awareness Month! It's time to increase the public's awareness of radon as a leading cause of #LungCancer, promote radon testing and mitigation, and advance the use of radon-resistant construction practices. Learn how to protect your home and family: LCRF.org/radon

Applications are open for the OUCH-International and LCRF Research Grant Program on the Effects of Air Pollution and Climate Change on Carcinogenesis and #LungCancer Prevalence. This collaboration seeks to fund projects studying the effect of climate on lung cancer. Read more: LCRF.org/rfp-OUCHI

LCRF is now accepting research program applications, advancing its mission to address critical challenges in #LungCancer by improving early detection, deepening understanding of lung cancer biology, overcoming drug resistance, and developing innovative treatment approaches. LCRF.org/RFPannouncement

Applications are now open for the OUCH-International and LCRF Research Grant Program on the Effects of Air Pollution and Climate Change on Carcinogenesis and #LungCancer Prevalence. View RFP and apply at LCRF.org/funding#OUCH.

#LungCancer research RFPs open: LCRF is accepting Letters of Intent for its 2026 grant program, which includes tracks on overcoming resistance, early detection, and leading edge research. View RFPs and apply: LCRF.org/funding

LCRF's Sr. Dir. Research & Administration, Dr. Dhru Deb, explains how early funding for NTRK gene fusion research led to the first targeted therapy for this driver. Our commitment to #LungCancer research continues to make an impact. Read more: LCRF.org/connecting3

New Year. New Goals. Go the Distance for Lung Cancer Research. Team LCRF is looking for runners and cyclists to go the distance for lung cancer research in the United Airlines NYC Half on March 15 and the TD Five Boro Bike tour on May 3! TeamLCRF.org 🏅

LCRF is pleased to announce five additional award recipients for its 2025 #LungCancer research grant program. Read more: LCRF.org/gr16a

Advice to the newly diagnosed. www.tiktok.com/t/ZP8yG66dB/ #cancer #lungcancer #lcsm

“Lung cancer tried to take my life three times. Research saved me—three times.” Judith’s story isn’t just powerful—it’s possible because of donors like you. Right now, someone else is waiting for their breakthrough. Give before midnight to DOUBLE your impact! LCRF.org/thirdchance

Today’s the last day to make a tax-deductible gift in 2025—and the last chance to have your donation DOUBLED. Judith survived #LungCancer three times, thanks to research made possible by donors like you. Give now and make 2x the impact: LCRF.org/thirdchance

#LungCancer is still surrounded by silence and stigma—but Judith, a 3x survivor, fights to make lung cancer impossible to ignore. Your support funds the research that saves lives. Donate by Dec 31 to DOUBLE your gift. End the stigma. End lung cancer. LCRF.org/thirdchance

“None of us are alone in this.” When Shane’s mom was diagnosed with #LungCancer, he found hope through community—and through research that gave her more time. Your support fuels that same hope. Donate by Dec 31 to double your gift and help fund the next breakthrough. LCRF.org/thirdchance

Yesterday, the FDA approved subcutaneous amivantamab for adult patients with EGFR-mutated non-small cell lung cancer (NSCLC.) This approval means shorter treatment times and fewer side effects. #lungcancer #QOL #lcsm www.fda.gov/drugs/resour...